THE EFFICACY AND SAFETY OF THE ALDOSE-REDUCTASE INHIBITOR TOLRESTAT IN THE TREATMENT OF CHRONIC SENSORIMOTOR DIABETIC NEUROPATHY

被引：0
|
作者：
BOULTON, AJM
ATIEA, J
DELEEUW, IH
LEMKES, H
MACLEOD, AF
MACRURY, S
SCARPELLO, JHB
SOMERS, G
TATTERSALL, RB
VANDERVEEN, EA
机构：
来源：
DIABETOLOGIA | 1989年 / 32卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A469 / A469
页数：1
相关论文
共 50 条
  • [1] A MULTICENTER TRIAL OF THE ALDOSE-REDUCTASE INHIBITOR, TOLRESTAT, IN PATIENTS WITH SYMPTOMATIC DIABETIC NEUROPATHY
    BOULTON, AJM
    LEVIN, S
    COMSTOCK, J
    [J]. DIABETOLOGIA, 1990, 33 (07) : 431 - 437
  • [2] A MULTICENTER TRIAL OF THE ALDOSE-REDUCTASE INHIBITOR TOLRESTAT, IN PATIENTS WITH SYMPTOMATIC DIABETIC PERIPHERAL NEUROPATHY
    MACLEOD, AF
    BOULTON, AJM
    OWENS, DR
    VANROOY, P
    VANGERVEN, JMA
    MACRURY, S
    SCARPELLO, JHB
    SEGERS, O
    HELLER, SR
    VANDERVEEN, EA
    [J]. DIABETES & METABOLISM, 1992, 18 (01): : 14 - 20
  • [3] TOLRESTAT - AN ALDOSE REDUCTASE INHIBITOR FOR DIABETIC PERIPHERAL NEUROPATHY
    WEINTRAUB, M
    STANDISH, R
    [J]. HOSPITAL FORMULARY, 1986, 21 (09): : 912 - &
  • [4] TREATMENT OF DIABETIC POLYNEUROPATHY WITH TOLRESTAT, AN ALDOSE REDUCTASE INHIBITOR
    GUILLEN, MA
    DELAVEGA, MS
    ZORRILLA, E
    HERNANDEZ, A
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1994, 55 (04): : 455 - 467
  • [5] ALDOSE REDUCTASE INHIBITOR (TOLRESTAT) THERAPY IN PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHY
    HARATI, Y
    NIAKAN, E
    COMSTOCK, JP
    LOGAN, C
    [J]. ANNALS OF NEUROLOGY, 1987, 22 (01) : 129 - 129
  • [6] CRANIAL NERVE NEUROPATHY OF DIABETIC RATS IS PREVENTED BY TOLRESTAT, AN ALDOSE REDUCTASE INHIBITOR
    NOTVEST, RR
    INSERRA, JJ
    KEIM, KL
    [J]. DIABETES, 1986, 35 : A206 - A206
  • [7] POSSIBLE EFFICACY OF TOLRESTAT (T), A NOVEL ALDOSE REDUCTASE INHIBITOR, IN THE TREATMENT OF DIABETIC HYPERTENSION
    RYDER, S
    SHAND, DG
    MULLANE, JF
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 217 - 217
  • [8] WITHDRAWAL OF THE ALDOSE REDUCTASE INHIBITOR TOLRESTAT IN PATIENTS WITH DIABETIC NEUROPATHY - EFFECT ON NERVE FUNCTION
    SANTIAGO, JV
    SONKSEN, PH
    BOULTON, AJM
    MACLEOD, A
    BEG, M
    BOCHENEK, W
    GRAEPEL, GJ
    GONEN, B
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1993, 7 (03) : 170 - 178
  • [9] HUMAN SAFETY PROFILE OF TOLRESTAT - AN ALDOSE REDUCTASE INHIBITOR
    RYDER, S
    SAROKHAN, B
    SHAND, DG
    MULLANE, JF
    [J]. DRUG DEVELOPMENT RESEARCH, 1987, 11 (02) : 131 - 143
  • [10] INFLUENCE OF PONALRESTAT, AN ALDOSE-REDUCTASE INHIBITOR, ON DIABETIC POLYNEUROPATHY
    STRACKE, H
    DIETRICH, E
    [J]. MEDIZINISCHE WELT, 1994, 45 (03): : 84 - 89
12345